1. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. Issue 11 (12th June 2018) Authors: Min, B-H; Hong, M; Lee, J H; Rhee, P-L; Sohn, T S; Kim, S; Kim, K-M; Kim, J J Journal: British journal of surgery Issue: Volume 105:Issue 11(2018) Page Start: 1480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients. (2nd February 2018) Authors: Kim, S T; Banks, K C; Pectasides, E; Kim, S Y; Kim, K; Lanman, R B; Talasaz, A; An, J; Choi, M G; Lee, J H; Sohn, T S; Bae, J M; Kim, S; Park, S H; Park, J O; Park, Y S; Lim, H Y; Kim, N K D; Park, W; Lee, H Journal: Annals of oncology Issue: Volume 29:Number 4(2018) Page Start: 1037 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗